Cargando…
Personalized Multimorbidity Management for Patients with Type 2 Diabetes Using Reinforcement Learning of Electronic Health Records
BACKGROUND: Comorbid chronic conditions are common among people with type 2 diabetes. We developed an artificial intelligence algorithm, based on reinforcement learning (RL), for personalized diabetes and multimorbidity management, with strong potential to improve health outcomes relative to current...
Autores principales: | Zheng, Hua, Ryzhov, Ilya O., Xie, Wei, Zhong, Judy |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer International Publishing
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7876533/ https://www.ncbi.nlm.nih.gov/pubmed/33570745 http://dx.doi.org/10.1007/s40265-020-01435-4 |
Ejemplares similares
-
Pharmaceutical cost and multimorbidity with type 2 diabetes mellitus using electronic health record data
por: Sancho-Mestre, Carla, et al.
Publicado: (2016) -
Reinforcement Learning Assisted Oxygen Therapy for COVID-19 Patients Under Intensive Care
por: Zheng, Hua, et al.
Publicado: (2021) -
Reinforcement learning assisted oxygen therapy for COVID-19 patients under intensive care
por: Zheng, Hua, et al.
Publicado: (2021) -
Italian guidelines on management of persons with multimorbidity and polypharmacy
por: Onder, Graziano, et al.
Publicado: (2022) -
Associations between PFAS occurrence and multimorbidity as observed in an electronic health record cohort
por: Ward-Caviness, Cavin K, et al.
Publicado: (2022)